Syntactx is a leading, full-service CRO with deep expertise in complex, interventional medical device and drug trials. Led by key thought leaders who understand first-hand what's at stake, clients count on us to synthesize the clinical evidence behind their innovative products for market approvals and broad market adoption. We provide solutions for: • Market Leaders • Emerging Companies • Early-Stage Startups • Physicians and Institutions Having long careers in clinical practice and academia, our world-renowned physicians were national principal investigators on multiple, landmark clinical trials for medicine’s most advanced technologies. They work in tandem with the company’s team of clinical and regulatory professionals who also understand first-hand about enrollment obstacles and regulatory challenges. Our team of experts can guide you through: - Strategy and Consulting - Clinical Operations - Regulatory Affairs - Data Sciences - Safety - Imaging Core Laboratory - Medical Writing Since 2010, Syntactx has enrolled over 200,000 subjects in North America, Europe, and Asia. Syntactx is technology-driven and committed to helping clients improve the lives of patients worldwide.
View Top Employees from Syntactx, Now Part of NAMSAWebsite | http://www.syntactx.com |
Revenue | $12 million |
Funding | $1 million |
Employees | 45 (45 on RocketReach) |
Founded | 2010 |
Address | 150 Greenwich St Fl 44, New York, New York 10007, US |
Phone | (212) 228-9000 |
Fax | (646) 375-3183 |
Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
Industry | Research Services, Hospitals & Clinics, Clinical Trials, Protocol Development, Healthcare, Health Care, Data Management, Consulting, Regulatory Authority Negotiation and Submission, Adverse Event Coding, Site Selection, CEC/DSMB Selection and Management, Site Contracting, Data Analysis, Site Management, Medical Writing, Site Monitoring, Reimbursement Strategy |
Web Rank | 14 Million |
Keywords | Syntactx |
Competitors | ClinSmart, LLC, Crystal Pharmatech, Health Decisions, A Division of Premier Research, Quality Data Services, Inc., Syreon: Celebrating 20 Years of Leading Research |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 54 Companies, NAICS Code 541712 Companies, NAICS Code 541 Companies, NAICS Code 6219 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 62199 Companies |
Looking for a particular Syntactx, Now Part of NAMSA employee's phone or email?
The Syntactx, Now Part of NAMSA annual revenue was $12 million in 2024.
James Evans is the Director of Finance of Syntactx, Now Part of NAMSA.
45 people are employed at Syntactx, Now Part of NAMSA.
Syntactx, Now Part of NAMSA is based in New York, New York.
The NAICS codes for Syntactx, Now Part of NAMSA are [621, 62, 54, 541712, 541, 6219, 54171, 5417, 62199].
The SIC codes for Syntactx, Now Part of NAMSA are [87, 873].